constellia | Procurement, empowered
constellia news
Strengthening Our Board for the Future of Procurement
We’re delighted to announce the appointment of David Taylor, formerly Deputy Government Chief Commercial Officer, Chief Commercial Officer in the Home Office and Chief Operating Officer at CIPS, as our new Non-Executive Director. David brings a wealth of experience in public and private sector procurement to our board at what Constellia believes is a pivotal moment in the procurement landscape.
Why This Appointment Matters Now
Timing is crucial as we face the most significant procurement change in decades, driven by the Government’s National Procurement Policy Statement, aimed at fostering innovation and supporting small businesses, alongside the Modern Industrial Strategy, Defence Industrial Strategy, and Small Business Strategy.
At Constellia, we manage over £400 million in public spending and support 3,000+ suppliers, mostly SMEs. We’ve seen how the right procurement approach can unlock innovation, increase competition, and deliver value for taxpayers.
The Value of Deep Expertise
David has over 30 years of experience in procurement and the public sector, including roles as Deputy Government Chief Commercial Officer and Chief Commercial Officer at the Home Office. He has played a key role in driving improvement and innovation in both public and private sectors.
His expertise will be vital as we work to improve accessibility for smaller businesses, which provide speed, innovation, and competitive pricing but are often excluded by procurement processes designed for large platform acquisitions.
Building for Tomorrow’s Challenges
The procurement landscape is evolving rapidly. The Government’s commitment to radical reform – from the three-tier procurement approach to the establishment of the Defence Office for Small Business Growth by January 2026 – creates both opportunities and challenges.
We see the impact of these changes. Shifting to three-month cycles for rapid commercial use is crucial for SMEs to compete. However, success needs expertise, experience, and understanding of government and industry. David’s appointment enhances our capacity to navigate this, bringing system insight to improve procurement for government, industry, and taxpayers.
Reflecting on the appointment, Constellia CEO Rob Levene said: “Constellia prides itself on procurement experience, expertise and talent. David is one of the most respected procurement leaders in the UK, and his appointment will help to ensure that we continue to deliver a gold standard service.”
David Taylor, Constellia’s new Non-Executive Director, added: “It is a huge privilege to be joining the board of one of the procurement sector’s most dynamic, innovative and fast-growing organisations. Constellia are already delivering extraordinarily fast, flexible and simplified procurement processes, which will in turn benefit taxpayers and private companies for many years to come. I’m very much looking forward to supporting the team in my new role, as we look towards the long-term stability and success of Constellia and our clients.”
About Constellia
Established in 2007, Constellia is a leading procurement solutions provider, managing over £400 million of spend across more than 250 public and private sector organisations.
Through its managed marketplace of more than 3,000 pre-approved suppliers, including micro-SMEs, SMEs and large organisations, Constellia’s neutral vendor model creates fair and equal access for suppliers of all sizes. It enables clients to procure goods, works, services and technology across more than 400 subcategories of spend, all through one simple and compliant route to market.
Constellia connects buyers with the right suppliers, enabling them to work together with transparency and efficiency while driving value for money, innovation and measurable social impact. As an employee-owned organisation, we put people at the heart of how procurement solutions are delivered across the Constellia community.
Sign Up to Our Newsletter
Sign up for updates, insights, events and more.
